These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9973381)
1. Processing and release of IL-16 from CD4+ but not CD8+ T cells is activation dependent. Wu DM; Zhang Y; Parada NA; Kornfeld H; Nicoll J; Center DM; Cruikshank WW J Immunol; 1999 Feb; 162(3):1287-93. PubMed ID: 9973381 [TBL] [Abstract][Full Text] [Related]
2. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells. Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772 [TBL] [Abstract][Full Text] [Related]
3. Tissue and T cell distribution of precursor and mature IL-16. Chupp GL; Wright EA; Wu D; Vallen-Mashikian M; Cruikshank WW; Center DM; Kornfeld H; Berman JS J Immunol; 1998 Sep; 161(6):3114-9. PubMed ID: 9743378 [TBL] [Abstract][Full Text] [Related]
4. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function. Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769 [TBL] [Abstract][Full Text] [Related]
5. Histamine h(4) and h(2) receptors control histamine-induced interleukin-16 release from human CD8(+) T cells. Gantner F; Sakai K; Tusche MW; Cruikshank WW; Center DM; Bacon KB J Pharmacol Exp Ther; 2002 Oct; 303(1):300-7. PubMed ID: 12235264 [TBL] [Abstract][Full Text] [Related]
6. Activation of caspase-3 by interferon alpha causes interleukin-16 secretion but fails to modulate activation induced cell death. Ludwiczek O; Kaser A; Koch RO; Vogel W; Cruikshank WW; Tilg H Eur Cytokine Netw; 2001; 12(3):478-86. PubMed ID: 11566629 [TBL] [Abstract][Full Text] [Related]
7. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes. Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009 [TBL] [Abstract][Full Text] [Related]
8. Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-beta1 on CD4+ and CD8+ naïve human T-cells. Gunnlaugsdottir B; Maggadottir SM; Ludviksson BR Int Immunol; 2005 Jan; 17(1):35-44. PubMed ID: 15557315 [TBL] [Abstract][Full Text] [Related]
9. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy. Chen HW; Liao CH; Ying C; Chang CJ; Lin CM Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844 [TBL] [Abstract][Full Text] [Related]
10. Histamine-induced secretion of lymphocyte chemoattractant factor from CD8+ T cells is independent of transcription and translation. Evidence for constitutive protein synthesis and storage. Laberge S; Cruikshank WW; Kornfeld H; Center DM J Immunol; 1995 Sep; 155(6):2902-10. PubMed ID: 7673707 [TBL] [Abstract][Full Text] [Related]
11. Differential kinetics of intracellular caspase-1-like and caspase-3-like enzyme activity in human alloreactive CD4(+) and CD8(+) T cells undergoing apoptosis. Ruiz P; Coleman L; Wang F; Enten J Clin Immunol; 2001 Mar; 98(3):308-12. PubMed ID: 11237553 [TBL] [Abstract][Full Text] [Related]
12. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation. Sepulveda H; Cerwenka A; Morgan T; Dutton RW J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007 [TBL] [Abstract][Full Text] [Related]
13. Rottlerin inhibits human T cell responses. Springael C; Thomas S; Rahmouni S; Vandamme A; Goldman M; Willems F; Vosters O Biochem Pharmacol; 2007 Feb; 73(4):515-25. PubMed ID: 17141738 [TBL] [Abstract][Full Text] [Related]
14. T cells for suicide gene therapy: activation, functionality and clinical relevance. Hollatz G; Grez M; Mastaglio S; Quaritsch R; Huenecke S; Ciceri F; Bonini C; Esser R; Klingebiel T; Kreuter J; Koehl U J Immunol Methods; 2008 Feb; 331(1-2):69-81. PubMed ID: 18155021 [TBL] [Abstract][Full Text] [Related]
15. Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway. Shin HC; Benbernou N; Esnault S; Guenounou M Cytokine; 1999 Apr; 11(4):257-66. PubMed ID: 10328864 [TBL] [Abstract][Full Text] [Related]
16. Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis (EAE). Skundric DS; Zhou W; Cruikshank WW; Dai R J Autoimmun; 2005 Nov; 25(3):206-14. PubMed ID: 16271292 [TBL] [Abstract][Full Text] [Related]
17. Response differences between human CD4(+) and CD8(+) T-cells during CD28 costimulation: implications for immune cell-based therapies and studies related to the expansion of double-positive T-cells during aging. Laux I; Khoshnan A; Tindell C; Bae D; Zhu X; June CH; Effros RB; Nel A Clin Immunol; 2000 Sep; 96(3):187-97. PubMed ID: 10964536 [TBL] [Abstract][Full Text] [Related]
18. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells. Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577 [TBL] [Abstract][Full Text] [Related]
19. CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack. Koehler H; Kofler D; Hombach A; Abken H Cancer Res; 2007 Mar; 67(5):2265-73. PubMed ID: 17332357 [TBL] [Abstract][Full Text] [Related]
20. A distinct role for ICOS-mediated co-stimulatory signaling in CD4+ and CD8+ T cell subsets. Watanabe M; Hara Y; Tanabe K; Toma H; Abe R Int Immunol; 2005 Mar; 17(3):269-78. PubMed ID: 15668466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]